ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,508Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 1187

$910K Total Retail Price of All Prescriptions

Rank: 38 out of 1187

271 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 271 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 11,060 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
PRAVASTATIN SODIUM 635 578 1 12
AMLODIPINE BESYLATE 306 305 2 2
PLAVIX 303 303 3 52
OMEPRAZOLE 292 288 4 5
METOPROLOL SUCCINATE 288 280 5 11
LOVAZA 283 275 6 53
NEXIUM 271 261 7 15
LEVOTHYROXINE SODIUM 256 256 8 3
ATORVASTATIN CALCIUM 241 241 9 6
CRESTOR 227 220 10 16
METFORMIN HCL 210 190 11 7
CLOPIDOGREL 209 209 12 33
METOPROLOL TARTRATE 208 199 13 10
SERTRALINE HCL 192 180 14 22
LIDODERM 183 179 15 80
LISINOPRIL 179 156 16 4
ZOLPIDEM TARTRATE 179 179 16 14
DIOVAN 170 164 18 17
DIOVAN HCT 164 153 19 40
JANUVIA 154 154 20 34
METFORMIN HCL ER 140 131 21 57
ATENOLOL 137 137 22 18
CHLORHEXIDINE GLUCONATE 127 127 23 245
NITROGLYCERIN PATCH 121 119 24 138
ISOSORBIDE MONONITRATE ER 121 121 24 66
PROAIR HFA 119 105 26 41
CARVEDILOL 104 104 27 19
LOSARTAN-HYDROCHLOROTHIAZIDE 103 103 28 56
EXELON 100 100 29 132
LISINOPRIL-HYDROCHLOROTHIAZIDE 100 96 29 39
MELOXICAM 97 97 31 49
IBANDRONATE SODIUM 94 94 32 191
CLONIDINE HCL 91 91 33 73
MECLIZINE HCL 90 90 34 112
DONEPEZIL HCL 84 84 35 26
LIPITOR 84 82 35 43
ALENDRONATE SODIUM 80 80 37 25
HYDROCHLOROTHIAZIDE 79 75 38 9
NAMENDA 79 79 38 44
NITROSTAT 75 75 40 347
SYNTHROID 74 70 41 46
FUROSEMIDE 73 73 42 8
AMLODIPINE BESYLATE-BENAZEPRIL 71 71 43 62
WARFARIN SODIUM 70 70 44 13
BONIVA 69 69 45 354
GLIPIZIDE ER 68 58 46 115
ZETIA 68 65 46 64
ESCITALOPRAM OXALATE 68 68 46 51
POLYETHYLENE GLYCOL 3350 68 68 46 86
AZITHROMYCIN 66 58 50 24
SINGULAIR 62 54 51 67
GLIPIZIDE XL 62 60 51 117
QUINAPRIL HCL 61 59 53 106
NIFEDIPINE ER 61 61 53 141
ZOSTAVAX 59 58 55 37
RAMIPRIL 59 48 55 36
BENICAR HCT 58 58 57 170
TRIBENZOR 57 53 58 320
POTASSIUM CHLORIDE 57 57 58 32
TRICOR 53 53 60 94
DICYCLOMINE HCL 50 49 61 241
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.